Susan J. Ermlich

Statistics

Publications

Citations

276

H-Index

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Susan J. Ermlich is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacokinetics, and headache disorders.

Publications per year

2000–2018

Publications

Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men

Hong Sun, William P. Kennedy, Darren Wilbraham et al. · SLEEP · 2013 · 159 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age

Susan J. Ermlich, Charles P. Andrews, Steven Folkerth et al. · Vaccine · 2018 · 43 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Single‐ and Multiple‐Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene‐Related Peptide Receptor Antagonist, in Adults

Tae Hyung Han, Rebecca Blanchard, John Palcza et al. · The Journal of Clinical Pharmacology · 2010 · 34 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Rizatriptan, a Novel 5-HT<SUB>1D/1B</SUB> Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects

Timothy Olah, Michael R. Goldberg, Y. Lee et al. · The Journal of Clinical Pharmacology · 2000 · 29 citations

Medicine, Pharmacokinetics, Pharmacology +16

The pharmacokinetics and tolerability of telcagepant, a novel calcitonin gene related peptide (CGRP) receptor antagonist, in healthy subjects and migraineurs

Han Th, RL Blanchard, John Palcza et al. · Ghent University Academic Bibliography (Ghent University) · 2009 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +12

1–5 of 5